x

Search for a clinical trial

* (*) mandatory field

29 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

AUSTRIA

SALZBURG
SALZBURG

A Phase Ib Dose Escalation Study of BCL201 in Combination With Idelalisib in Patients With Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL) - AT
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Innere Medizin III

GERMANY

Bayern
MÜNCHEN

SPAIN

Comunidad Valenciana
VALENCIA

Ongoing trial
Dose Optimization Study of Idelalisib in Follicular Lymphoma and Small Lymphocytic Lymphoma - ES
Hospital Universitario y Politécnico La Fe
Servicio de Oncología Médica

UNITED KINGDOM

West Midlands
BIRMINGHAM

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Recruiting trial
Ongoing trial
Dose Optimization Study of Idelalisib in Follicular Lymphoma-GB
Institution: Information not provided - US

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Dose Optimization Study of Idelalisib in Follicular Lymphoma
Institution: Information not provided - US